FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:586-595 February 10, 2005 Number 6 Next

	Full Text PDF PDA Full Text Supplementary Material Editorial by Bozzette, S. A. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Although the Centers for Disease Control and Prevention (CDC) recommend routine HIV counseling, testing, and referral (HIVCTR) in settings with at least a 1 percent prevalence of HIV, roughly 280,000 Americans are unaware of their human immunodeficiency virus (HIV) infection. The effect of expanded screening for HIV is unknown in the era of effective antiretroviral therapy.

Methods We developed a computer simulation model of HIV screening and treatment to compare routine, voluntary HIVCTR with current practice in three target populations: "high-risk" (3.0 percent prevalence of undiagnosed HIV infection; 1.2 percent annual incidence); "CDC threshold" (1.0 percent and 0.12 percent, respectively); and "U.S. general" (0.1 percent and 0.01 percent). Input data were derived from clinical trials and observational cohorts. Outcomes included quality-adjusted survival, cost, and cost-effectiveness.

Results In the high-risk population, the addition of one-time screening for HIV antibodies with an enzyme-linked immunosorbent assay (ELISA) to current practice was associated with earlier diagnosis of HIV (mean CD4 cell count at diagnosis, 210 vs. 154 per cubic millimeter). One-time screening also improved average survival time among HIV-infected patients (quality-adjusted survival, 220.7 months vs. 219.8 months). The incremental cost-effectiveness was $36,000 per quality-adjusted life-year gained. Testing every five years cost $50,000 per quality-adjusted life-year gained, and testing every three years cost $63,000 per quality-adjusted life-year gained. In the CDC threshold population, the cost-effectiveness ratio for one-time screening with ELISA was $38,000 per quality-adjusted life-year gained, whereas testing every five years cost $71,000 per quality-adjusted life-year gained, and testing every three years cost $85,000 per quality-adjusted life-year gained. In the U.S. general population, one-time screening cost $113,000 per quality-adjusted life-year gained.

Conclusions In all but the lowest-risk populations, routine, voluntary screening for HIV once every three to five years is justified on both clinical and cost-effectiveness grounds. One-time screening in the general population may also be cost-effective.

Source Information

From the Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, Conn. (A.D.P.); and the Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health (M.C.W., K.A.F.), the Divisions of Infectious Disease and General Medicine and the Partners AIDS Research Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School (A.D.K., H.Z., K.A.F., R.P.W.), the Department of Epidemiology, Harvard School of Public Health (G.R.S.), the Departments of Biostatistics and Epidemiology, Boston University School of Public Health (E.L., K.A.F.), and the Division of Infectious Disease, Department of Medicine, Brigham and Women's Hospital (R.P.W.) — all in Boston.

Address reprint requests to Dr. Paltiel at the Department of Epidemiology and Public Health, Yale School of Medicine, 60 College St., New Haven, CT 06520-8034, or at david.paltiel{at}yale.edu.

Full Text of this Article

Related Letters:

Cost-Effectiveness of Screening for HIV
Taiwo B. O., Thrasher A. D., Ford C. L., Nearing K. A., da Silveira E., Sanders G. D., Bayoumi A. M., Owens D. K., Paltiel A. D., Walensky R. P., Freedberg K. A.
Extract | Full Text | PDF  
N Engl J Med 2005; 352:2137-2139, May 19, 2005. Correspondence

This article has been cited by other articles:

• Bernstein, K. T., Liu, K.-L., Begier, E. M., Koblin, B., Karpati, A., Murrill, C. (2008). Same-Sex Attraction Disclosure to Health Care Providers Among New York City Men Who Have Sex With Men: Implications for HIV Testing Approaches. Arch Intern Med 168: 1458-1464 [Abstract] [Full Text]  
• Sanders, G. D., Bayoumi, A. M., Holodniy, M., Owens, D. K. (2008). Cost-Effectiveness of HIV Screening in Patients Older than 55 Years of Age. ANN INTERN MED 148: 889-903 [Abstract] [Full Text]  
• Torian, L. V., Wiewel, E. W., Liu, K.-L., Sackoff, J. E., Frieden, T. R. (2008). Risk Factors for Delayed Initiation of Medical Care After Diagnosis of Human Immunodeficiency Virus. Arch Intern Med 168: 1181-1187 [Abstract] [Full Text]  
• Kitkungvan, D., Apisarnthanarak, A., Plengpart, P., Mundy, L. M (2008). Fever of unknown origin in patients with HIV infection in Thailand: an observational study and review of the literature. Int J STD AIDS 19: 232-235 [Abstract] [Full Text]  
• Hornberger, J., Holodniy, M., Robertus, K., Winnike, M., Gibson, E., Verhulst, E. (2007). A Systematic Review of Cost-Utility Analyses in HIV/AIDS: Implications for Public Policy. Med Decis Making 27: 789-821 [Abstract]  
• Owens, D. K., Sundaram, V., Lazzeroni, L. C., Douglass, L. R., Sanders, G. D., Taylor, K., VanGroningen, R., Shadle, V. M., McWhorter, V. C., Agoncillo, T., Haren, N., Nyland, J., Tempio, P., Khayr, W., Dietzen, D. J., Jensen, P., Simberkoff, M. S., Bozzette, S. A., Holodniy, M. (2007). Prevalence of HIV Infection Among Inpatients and Outpatients in Department of Veterans Affairs Health Care Systems: Implications for Screening Programs for HIV. Am. J. Public Health 97: 2173-2178 [Abstract] [Full Text]  
• DeRiemer, K., Kawamura, L. M., Hopewell, P. C., Daley, C. L. (2007). Quantitative Impact of Human Immunodeficiency Virus Infection on Tuberculosis Dynamics. Am. J. Respir. Crit. Care Med. 176: 936-944 [Abstract] [Full Text]  
• Hutton, D. W., Tan, D., So, S. K., Brandeau, M. L. (2007). Cost-Effectiveness of Screening and Vaccinating Asian and Pacific Islander Adults for Hepatitis B. ANN INTERN MED 147: 460-469 [Abstract] [Full Text]  
• Barham, L, Lewis, D, Latimer, N (2007). One to one interventions to reduce sexually transmitted infections and under the age of 18 conceptions: a systematic review of the economic evaluations. Sex. Transm. Infect. 83: 441-446 [Abstract] [Full Text]  
• Delpierre, C., Cuzin, L., Lert, F. (2007). Routine testing to reduce late HIV diagnosis in France. BMJ 334: 1354-1356 [Full Text]  
• Harper, S., Lynch, J., Burris, S., Davey Smith, G. (2007). Trends in the Black-White Life Expectancy Gap in the United States, 1983-2003. JAMA 297: 1224-1232 [Abstract] [Full Text]  
• Fang, C.T., Chang, Y.Y., Hsu, H.M., Twu, S.J., Chen, K.T., Lin, C.C., Huang, L.Y.L., Chen, M.Y., Hwang, J.S., Wang, J.D., Chuang, C.Y. (2007). Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. QJM 100: 97-105 [Abstract] [Full Text]  
• Heimer, R., Grau, L. E., Curtin, E., Khoshnood, K., Singer, M. (2007). Assessment of HIV Testing of Urban Injection Drug Users: Implications for Expansion of HIV Testing and Prevention Efforts. Am. J. Public Health 97: 110-116 [Abstract] [Full Text]  
• Rein, D. B., Hicks, K. A., Wirth, K. E., Billah, K., Finelli, L., Fiore, A. E., Hoerger, T. J., Bell, B. P., Armstrong, G. L. (2007). Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United States. Pediatrics 119: e12-e21 [Abstract] [Full Text]  
• Paltiel, A. D., Walensky, R. P., Schackman, B. R., Seage, G. R. III, Mercincavage, L. M., Weinstein, M. C., Freedberg, K. A. (2006). Expanded HIV Screening in the United States: Effect on Clinical Outcomes, HIV Transmission, and Costs. ANN INTERN MED 145: 797-806 [Abstract] [Full Text]  
• Branson, B. M. (2006). To Screen or Not to Screen: Is That Really the Question?. ANN INTERN MED 145: 857-859 [Full Text]  
• Aberg, J. A. (2006). The changing face of HIV care: common things really are common.. ANN INTERN MED 145: 463-465 [Full Text]  
• Koo, D. J., Begier, E. M., Henn, M. H., Sepkowitz, K. A., Kellerman, S. E. (2006). HIV Counseling and Testing: Less Targeting, More Testing. Am. J. Public Health 96: 962-964 [Full Text]  
• Friedman, S. R., Sherman, S. G., Flanigan, T. P., Beckwith, C., Carpenter, C. C.J., Frieden, T. R., Kellerman, S. E., Das-Douglas, M. (2006). Public health principles for the HIV epidemic.. NEJM 354: 877-878 [Full Text]  
• Beckwith, C. G., Flanigan, T. P., Rio, C. d., Bartlett, J. G. (2005). Screening for HIV. ANN INTERN MED 143: 916-916 [Full Text]  
• Frieden, T. R., Das-Douglas, M., Kellerman, S. E., Henning, K. J. (2005). Applying public health principles to the HIV epidemic.. NEJM 353: 2397-2402 [Full Text]  
• Janssen, R. S., McKenna, M. T. (2005). CDC: HIV Prevention Efforts. Health Aff (Millwood) 24: 1683-1683 [Full Text]  
• Hammer, S. M. (2005). Clinical practice. Management of newly diagnosed HIV infection.. NEJM 353: 1702-1710 [Full Text]  
• Lubelchek, R., Kroc, K., Hota, B., Sharief, R., Muppudi, U., Pulvirenti, J., Weinstein, R. A. (2005). The Role of Rapid vs Conventional Human Immunodeficiency Virus Testing for Inpatients: Effects on Quality of Care. Arch Intern Med 165: 1956-1960 [Abstract] [Full Text]  
• Padeh, Y. C., Rubinstein, A., Shliozberg, J. (2005). Common Variable Immunodeficiency and Testing for HIV-1. NEJM 353: 1074-1075 [Full Text]  
• Stange, K. C. (2005). In This Issue: Subtle Clinical Policy. Ann Fam Med 3: 386-388 [Full Text]  
• Coco, A. (2005). The Cost-Effectiveness of Expanded Testing for Primary HIV Infection. Ann Fam Med 3: 391-399 [Abstract] [Full Text]  
• U.S. Preventive Services Task Force*, (2005). Screening for HIV: Recommendation Statement. ANN INTERN MED 143: 32-37 [Abstract] [Full Text]  
• Chou, R., Huffman, L. H., Fu, R., Smits, A. K., Korthuis, P. T. (2005). Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED 143: 55-73 [Abstract] [Full Text]  
• Taiwo, B. O., Thrasher, A. D., Ford, C. L., Nearing, K. A., da Silveira, E., Sanders, G. D., Bayoumi, A. M., Owens, D. K., Paltiel, A. D., Walensky, R. P., Freedberg, K. A. (2005). Cost-Effectiveness of Screening for HIV. NEJM 352: 2137-2139 [Full Text]  
• Walensky, R. P., Weinstein, M. C., Smith, H. E., Freedberg, K. A., Paltiel, A. D. (2005). Optimal Allocation of Testing Dollars: The Example of HIV Counseling, Testing, and Referral. Med Decis Making 25: 321-329 [Abstract]  
• (2005). Renewed Interest in Routine HIV Screening. AIDS Clin Care 2005: 2-2 [Full Text]  
• (2005). Routine HIV Screening in the U.S.: Cost-Effective?. JWatch Infect. Diseases 2005: 2-2 [Full Text]  
• (2005). Time to Make HIV Screening Routine in the U.S.?. AIDS Clin Care 2005: 4-4 [Full Text]  
• Bozzette, S. A. (2005). Routine Screening for HIV Infection -- Timely and Cost-Effective. NEJM 352: 620-621 [Full Text]